India's First Upright Proton Therapy Set for Fortis FMRI
Fortis Memorial Research Institute in Gurugram has announced plans to adopt upright proton therapy. Consequently, the flagship hospital will become the first healthcare provider in India to deploy this cutting-edge platform. Additionally, the institution aims to advance precision cancer treatment across the country through this strategic investment.
The Mechanics of Upright Proton Therapy
Conventional proton platforms rotate massive gantries around supine patients. In contrast, upright proton therapy utilizes a stationary horizontal beam line. The Mevion S250-FIT platform integrates Leo Cancer Care's Marie positioning technology. As a result, clinicians position patients comfortably in an upright, seated posture. Moreover, the Marie system features continuous 360-degree rotation and integrated computed tomography imaging. RaySearch Laboratories provides the RayStation treatment planning software to coordinate dose calculations. Therefore, the setup replaces heavy rotating machinery with an elegant, patient-centric design.
Clinical Benefits and Dosimetric Precision
Standard radiation modalities employ photon beams that pass entirely through the body. Consequently, conventional X-rays expose normal tissues to unnecessary exit doses. Proton therapy delivers radiation directly to the target volume through the Bragg peak phenomenon. Thus, the beam stops abruptly inside the tumor and spares downstream healthy tissue. Furthermore, this extreme precision protects vital organs such as the heart, brain, and spinal cord. Pediatric oncology patients benefit significantly from this reduced collateral exposure. For instance, lower radiation scatter minimizes long-term growth complications and secondary malignancy risks in children.
Infrastructure Advantages and Practical Implementation
Traditional proton therapy facilities require massive multistory vaults and extensive radiation shielding. However, the compact Mevion accelerator fits neatly into standard treatment spaces. In addition, the seated configuration optimizes natural breathing mechanics for patients with thoracic lesions. Dyspneic individuals often breathe more easily while seated rather than lying flat. Nevertheless, Fortis must secure regulatory approvals from Indian authorities before initiating clinical treatments. Site preparations are also underway to house the new technology in Gurugram. Ultimately, this installation promises to expand advanced radiation therapy access across Northern India.
Frequently Asked Questions
Q1: What makes upright proton therapy different from conventional proton therapy?
Upright systems position the patient vertically in a robotic chair instead of rotating a huge gantry around a supine table. Furthermore, this approach relies on a fixed beamline, which significantly reduces bunker footprint and equipment costs.
Q2: Which cancer types benefit most from this technology?
The platform excels at treating pediatric tumors and cancers near critical organs like the brain and spinal cord. Additionally, seated positioning provides superior comfort for patients suffering from respiratory compromise.
Q3: When will the system become operational at Fortis Gurugram?
The clinical launch will occur following regulatory clearance and site preparation. Therefore, the exact timeline depends on final statutory approvals from radiation safety authorities.
References
- Fortis to install upright proton therapy system to advance cancer care - ETHealthworld
- Fortis Healthcare to Install India's First Upright Proton Therapy System, Advancing Precision Cancer Care - PR Newswire
- MEVION S250-FIT: Proton Therapy That FITs Inside A LINAC Vault - Leo Cancer Care
